Premium for Ranbaxy buy among the highest

-

Most other Indian buyouts at 10-20% premium


Shanthi Venkataraman

Advertisement

BL Research Bureau The 30 per cent premium over the ruling market price that Daiichi Sankyo is paying to buy out the promoters of Ranbaxy Laboratories, may be among the highest paid for such a takeover of an Indian company over the past two years.

Acquirers have usually paid a premium of 10-20 per cent over the prevailing market price of the target companies, in recent acquisitions where promoters have shed a majority of their stake.

How much more

There are not too many instances of Indian promoters parting with their control over a key listed company. Recent instances of Indian promoters cashing out on a big chunk of their holdings include the complete exit of the Burmans from Dabur Pharma and Aztec Software's promoters selling out their stake to Mindtree Consulting. The buyers paid a 20 per cent premium over market price in Dabur Pharma's case.

But the premium was insignificant in the case of Aztec Software. Vedanta's acquisition of Mitsui's 51 per cent stake in Sesa Goa, the Kingfisher group's acquisition of Deccan Aviation, Grasim's exit from Shree Digvijay Cement and private-equity major Blackstone's buyout of a 50 per cent stake in Gokaldas Exports were prominent deals in 2007 that saw promoters cashing in on their stakes in listed companies.

The year 2006 was notable for cement major Holcim's acquisition of the 14.7 per cent promoter stake in Gujarat Ambuja Cements (now Ambuja Cements) and Mylan's acquisition of a 51 per cent stake in Matrix Laboratories.

The premium to the prevailing market price, for these deals, was on an average 20 per cent. Notably, both the pharmaceutical companies Dabur Pharma and Matrix Laboratories saw the buyer pay only a 10 per cent premium to the prevailing market price. Holcim's buyout of the promoter's stake in Gujarat Ambuja is also memorable. While Gujarat Ambuja's promoters received a 20 per cent premium for a "non-compete fee", the open offer to shareholders was made at the prevailing market price. This trend suggests that shareholders have indeed got a meaty premium for their shares in Ranbaxy.

Takeover buzz effect

A point worth noting, however, is that in a number of instances of promoters cashing out, the stock price of the target company has run up ahead of the acquisition announcement on "takeover buzz". This has automatically reduced the gap or premium between the offer price and the ruling market price at the time of the big announcement.

There also haven't been too many instances where promoters have completely sold out their stake in the target company. In the case of Deccan Aviation, Matrix Labs and Gokaldas Exports, for instance, promoters ceded control, but held on to a smaller stake in their companies.

Popular posts from this blog

IOB capitalises on hike in stake by LIC

-
Indian Overseas Bank rose 1.53% to Rs 46.45 at 10:31 IST on BSE, after the biggest domestic instutional investors Life Insurance Corporation of India hiked its stake in the state-run bank. The bank made this announcement after trading hours on Wednesday, 25 March 2009. Meanwhile, the BSE Sensex was up 126.19 points, or 1.31%, to 9,794.09. On BSE, 31,003 shares were traded in the counter. The stock had an average daily volume of 1.93 lakh shares in the past one quarter. The stock hit a high of Rs 47 and a low of Rs 45.95 so far during the day. The stock hit a 52-week high of Rs 156.80 on 2 May 2008 and a 52-week low of Rs 37.55 on 9 March 2009. The mid-cap bank stock had underperformed the market over the past one month till 25 March 2009, falling 3.17% as compared to the Sensex's 8.60% rise. It had also underperformed the market in the past one quarter, declining 33.94% as compared to the Sensex's 1.04% rise. The bank's current equ The current price of ...
Read more

Lok Housing & Constructions builds on fund raising plans

-
Lok Housing & Constructions jumped 6.99% to Rs 107.90 at 11:20 IST on BSE ahead of a board meeting to consider fund raising options from both foreign and local market, including an institutional placement. Meanwhile, the BSE Sensex was down 50.50 points, or 0.30%, at 15203.73. On BSE, 1.86 lakh shares were traded in the counter. The scrip had an average daily volume of 4.74 lakh shares in the past one quarter. The stock hit a high of Rs 115 and a low of Rs 102 so far during the day. The stock had a 52-week high of Rs 390.50 on 1 January 2008 and a 52-week low of Rs 96.25 on 12 June 2008. The scrip had underperformed the market over the past one month till 12 June 2008, falling 26.55% compared to the Sensex's 10.18% decline. It had also underperformed the market in the past one quarter, falling 31.39% compared to Sensex's 3.24% fall. The small-cap housing projects developer has an equity capital of Rs 42.88 crore. Face value per share is Rs 10. The current...
Read more

economic times picks

-
CMP: Rs 70.50 Target Price: Rs 90 CLSA Asia-Pacific Markets maintains an 'outperform' on Jagran Prakashan, with a 12-month price target of Rs 90. "An economic slowdown notwithstanding, improving literacy and income levels in Hindi heartland imply that drivers for Jagran's growth are still in place. With a 35% ad rate hike in 2008, Jagran continues to narrow the gap with its more expensive English rivals," the foreign brokerage said in a client note, after a Q&A reply from the management. "Rising newsprint prices have made Jagran cautious on launching new editions in FY09 and its focus this year will be profitability. While management has budgeted for a minor increase in FY10 newsprint prices, it believes that prices are likely to peak in Q2FY08 and decline thereon," it added. Neyveli Lignite CMP: Rs 117.15 Target Price: Rs 160 MERRILL Lynch has maintained its 'neutral' rating on Neyveli Lignite, with a price target of Rs 160 ...
Read more